Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-124566
Filing Date
2022-12-05
Accepted
2022-12-05 16:13:38
Documents
1
Period of Report
2022-12-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2232008-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2232008-2_4seq1.xml 4 3574
  Complete submission text file 0001104659-22-124566.txt   5269
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16760 SW UPPER BOONES FERRY RD SUITE 101 PORTLAND X1 97224
Business Address
Burns John Thomas (Reporting) CIK: 0001568734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 221445088